| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/22/2002 | US6340671 Stable compositions for parenteral administration and their use |
| 01/22/2002 | US6340591 Integrative protein-DNA cochleate formulations and methods for transforming cells |
| 01/22/2002 | US6340495 Device including a chromophoric composition to be applied to the skin, a method of fabricating such a device, and uses therefor |
| 01/22/2002 | US6340478 Storage stability |
| 01/22/2002 | US6340476 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 01/22/2002 | US6340475 Extending the duration of drug release within the stomach during the fed mode |
| 01/22/2002 | US6340474 Composition for potentiating a growth hormone and a method for preparation of said composition |
| 01/22/2002 | US6340473 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| 01/22/2002 | US6340472 Method for reducing onset time of pharmaceutically active compounds |
| 01/22/2002 | US6340471 Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
| 01/22/2002 | US6340469 For prophylaxis of mastitis in cows |
| 01/22/2002 | US6340467 Useful as an ointment, balm or salve for wounds |
| 01/22/2002 | US6340457 Pharmaceutical and alimentary compositions containing bacteria of genus acetobacter |
| 01/22/2002 | US6340456 For oral hygiene, drugs |
| 01/22/2002 | US6340360 System for cell growth |
| 01/22/2002 | CA2216560C New cellulosic materials for incorporation into food products and methods of making same |
| 01/22/2002 | CA2121435C Aqueous pharmaceutical suspension and process for preparation thereof |
| 01/22/2002 | CA2097801C Method of producing collagen particles, and the use of such particles as substrates for active substances |
| 01/22/2002 | CA2095728C A gel-forming liquid carrier composition |
| 01/22/2002 | CA2055339C Biocompatible gradient controlled release implant |
| 01/22/2002 | CA2036906C Coatings for stable sustained release preparations |
| 01/22/2002 | CA2027876C Use of substituted imidazoles |
| 01/22/2002 | CA2019974C Treatment of inflammation |
| 01/20/2002 | CA2358356A1 Pharmaceutical composition containing citalopram |
| 01/19/2002 | CA2315815A1 Topical pain relief composition and carrier |
| 01/17/2002 | WO2002004623A2 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 01/17/2002 | WO2002004616A1 RECOMBINANT α-L-IDURONIDASE, METHODS FOR PRODUCING AND PURIFYING THE SAME AND METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES THEREOF |
| 01/17/2002 | WO2002004570A2 Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| 01/17/2002 | WO2002004487A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 01/17/2002 | WO2002004202A1 Substrates for powder deposition containing conductive domains |
| 01/17/2002 | WO2002004067A1 Method and device for avoiding alteration of a substance having biological activities |
| 01/17/2002 | WO2002004016A1 Enteric preparations containing physiologically active peptides |
| 01/17/2002 | WO2002004012A1 Anhydrous pharmaceutical composition of vancomycin for topical use |
| 01/17/2002 | WO2002004008A2 Methods of therapy with thrombin derived peptides |
| 01/17/2002 | WO2002003998A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/17/2002 | WO2002003989A2 Use of substituted indole compounds for treating sphincter incontinence |
| 01/17/2002 | WO2002003987A2 Pharmaceutical compositions of estrogenic agents |
| 01/17/2002 | WO2002003973A2 Compositions comprising isosorbide dinitrate and methods for treatment of anal fissure |
| 01/17/2002 | WO2002003969A2 Transdermal therapeutic system for highly dispersed silicon dioxide |
| 01/17/2002 | WO2002003968A1 Delivery capsules |
| 01/17/2002 | WO2002003967A1 Film-coating composition based on cellulose derivatives and sugar alcohols |
| 01/17/2002 | WO2002003966A2 Method and materials for controlling migration of binder liquid in a powder |
| 01/17/2002 | WO2002003965A1 Method for formulating healthcare products with enhanced stability |
| 01/17/2002 | WO2002003964A1 Oral pharmaceutical composition with controlled release and prolonged absorption |
| 01/17/2002 | WO2002003963A1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient |
| 01/17/2002 | WO2002003962A2 Drug delivery system for poorly water soluble drugs |
| 01/17/2002 | WO2002003961A1 Microspheres and adjuvants for dna vaccine delivery |
| 01/17/2002 | WO2002003960A1 Particulate vectors for improving oral absorption of active principles |
| 01/17/2002 | WO2002003959A1 Drug delivery formulations and targeting |
| 01/17/2002 | WO2002003958A1 Novel aerosol formulation containing a polar fluorinated molecule |
| 01/17/2002 | WO2002003957A2 Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same |
| 01/17/2002 | WO2002003956A1 Cough treatment |
| 01/17/2002 | WO2002003955A1 Fast release bioadhesive microspheres for the sublingual administration of proximate principles |
| 01/17/2002 | WO2002003954A2 Non swellable suppository comprising at least one biocompatible, non-biodegradable polymer and a controlled release formulation |
| 01/17/2002 | WO2002003924A1 Method and kit for moisturizing the surface of the eye |
| 01/17/2002 | WO2002003914A2 Improved thyroid hormone formulations |
| 01/17/2002 | WO2002003896A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 01/17/2002 | WO2002003871A1 Use of a liquid medicament in surgical high pressure liquid jet devices |
| 01/17/2002 | WO2002003848A2 Method for opening the blood-brain barrier |
| 01/17/2002 | WO2002003800A1 Device and method for photoactivated drug therapy |
| 01/17/2002 | WO2001078693A3 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 01/17/2002 | WO2001068138A3 Intradermal-penetration agents for topical local anesthetic administration |
| 01/17/2002 | WO2001059067A3 A group of anti-cancer compounds with specific structure and their production method |
| 01/17/2002 | WO2001054672A3 Closure of bacterial ghosts |
| 01/17/2002 | WO2001049249A3 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 01/17/2002 | WO2001047560A3 Particulate vitamin composition |
| 01/17/2002 | WO2001043765A3 Method for localized administration of fibrinolytic metalloproteinases |
| 01/17/2002 | WO2001043722A3 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 01/17/2002 | WO2001041775A3 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
| 01/17/2002 | WO2001041740A3 Reconstitution of purified membrane proteins into preformed liposomes |
| 01/17/2002 | WO2001040446A3 Pour-on formulations |
| 01/17/2002 | WO2001039815A3 Targeted drug delivery with a cd44 receptor ligand |
| 01/17/2002 | WO2001037847A3 Nontoxic vernix compositions and method of producing |
| 01/17/2002 | WO2001035906A3 Personal care articles comprising a hydrophilic conditioning agent exhibiting a defined leaching value |
| 01/17/2002 | WO2001035905A3 Personal care articles comprising cationic polymer coacervate compositions |
| 01/17/2002 | WO2001031051A3 Antisense modulation of protein kinase c-theta expression |
| 01/17/2002 | WO2001030997A3 Microbe, microbial exopolysaccharide, and uses thereof |
| 01/17/2002 | WO2001030996A3 Microbial exopolysaccharide and uses thereof |
| 01/17/2002 | WO2001030362A3 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001021259A3 Use and compositions for treating platelet-related disorders using anagrelide |
| 01/17/2002 | WO2001019407A3 Taxane prodrugs |
| 01/17/2002 | WO2001019406A3 Amphiphilic prodrugs |
| 01/17/2002 | WO2001019305A8 Water absorbent keratin and gel formed therefrom |
| 01/17/2002 | WO2001010468A3 Drug-carrier complexes and methods of use thereof |
| 01/17/2002 | WO2000074649A3 Ophthalmic histamine compositions and uses thereof |
| 01/17/2002 | WO2000061129A3 S-hydroxynefazodone |
| 01/17/2002 | US20020007294 System and method for rapidly customizing a design and remotely manufacturing biomedical devices using a computer system |
| 01/17/2002 | US20020007173 Method of inducing a CTL response |
| 01/17/2002 | US20020007073 Capable of producing complexes with polynucleotides (DNA, RNA, antisense oligonucleotides, ribozymes); suitable as vectors for transfection |
| 01/17/2002 | US20020006965 Methods and compositions for treating depression and other disorders using optically pure (-)-bupropion |
| 01/17/2002 | US20020006961 Inflammation modulator, antioxidant; administering moisturizing buffered saline solution |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006933 Method for treating sexual dysfunction with apomorphine at specified plasma concentration levels |
| 01/17/2002 | US20020006921 Dopaminergic agent |
| 01/17/2002 | US20020006919 Drugs, solid form |
| 01/17/2002 | US20020006913 Maintenance of Dna; reduce damage |
| 01/17/2002 | US20020006649 Matrix; for use in wound healing |
| 01/17/2002 | US20020006648 Free-form fabrication using multi-photon excitation |
| 01/17/2002 | US20020006446 Five medicinal plants from Thailand, comprising Houttuynia cordata, Combretum quadrangulare, Mimusops elengi, Randia siamensis, and Borassus flabellifer; maintain Kamofsky performance status greater than or equal to ninety |